Search research articles
Contact Us
Filters
Showing results (81-90 of 149) with videos related to
Page
of 15
Sort By:
BMC Cancer
|
February 10, 2019
Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
Alex Molassiotis, Hui Lin Cheng, Violeta Lopez, et al.
British Journal of Cancer
|
February 16, 2023
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials
Jerold Loh, Jiaxuan Wu, Jenny Chieng, et al.
Brain and Behavior
|
May 8, 2019
Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy
Alex Molassiotis, Hui Lin Cheng, Kwun To Leung, et al.
The Journal of Biological Chemistry
|
December 29, 2019
Activation of sphingosine 1-phosphate receptor 2 attenuates chemotherapy-induced neuropathy
Wei Wang, Ping Xiang, Wee Siong Chew, et al.
Gut
|
November 24, 2020
Spatial profiling of gastric cancer patient-matched primary and locoregional metastases reveals principles of tumour dissemination
Raghav Sundar, Drolaiz Hw Liu, Gordon Ga Hutchins, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
June 6, 2022
Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy
Joe Yeong, Huey Yew Jeffrey Lum, Chong Boon Teo, et al.
Targeted Oncology
|
February 23, 2022
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
Matilda Xinwei Lee, Andrea L A Wong, Samuel Ow, et al.
BMJ (Clinical Research Ed.)
|
March 3, 2022
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
Molecular Cancer Therapeutics
|
January 26, 2019
First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors
Akihiko Shimomura, Noboru Yamamoto, Shunsuke Kondo, et al.
International Journal of Colorectal Disease
|
October 27, 2021
Small bowel adenocarcinoma in Crohn's disease: a systematic review and meta-analysis of the prevalence, manifestation, histopathology, and outcomes
Yip Han Chin, Sneha Rajiv Jain, Ming Hui Lee, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 149) with videos related to
Sort By:
Page
of 15
BMC Cancer
|
February 10, 2019
Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
Alex Molassiotis, Hui Lin Cheng, Violeta Lopez, et al.
British Journal of Cancer
|
February 16, 2023
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials
Jerold Loh, Jiaxuan Wu, Jenny Chieng, et al.
Brain and Behavior
|
May 8, 2019
Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy
Alex Molassiotis, Hui Lin Cheng, Kwun To Leung, et al.
The Journal of Biological Chemistry
|
December 29, 2019
Activation of sphingosine 1-phosphate receptor 2 attenuates chemotherapy-induced neuropathy
Wei Wang, Ping Xiang, Wee Siong Chew, et al.
Gut
|
November 24, 2020
Spatial profiling of gastric cancer patient-matched primary and locoregional metastases reveals principles of tumour dissemination
Raghav Sundar, Drolaiz Hw Liu, Gordon Ga Hutchins, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
June 6, 2022
Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy
Joe Yeong, Huey Yew Jeffrey Lum, Chong Boon Teo, et al.
Targeted Oncology
|
February 23, 2022
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
Matilda Xinwei Lee, Andrea L A Wong, Samuel Ow, et al.
BMJ (Clinical Research Ed.)
|
March 3, 2022
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
Molecular Cancer Therapeutics
|
January 26, 2019
First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors
Akihiko Shimomura, Noboru Yamamoto, Shunsuke Kondo, et al.
International Journal of Colorectal Disease
|
October 27, 2021
Small bowel adenocarcinoma in Crohn's disease: a systematic review and meta-analysis of the prevalence, manifestation, histopathology, and outcomes
Yip Han Chin, Sneha Rajiv Jain, Ming Hui Lee, et al.
Page
of 15